Increasing Copays for Brand Medicines Used by Low-Income Beneficiaries May Compromise Access to Care, Harm Patient Outcomes, and Raise Overall Medicare Costs

First Page		Document Content
Date: 2014-01-28 14:35:13 Medicine Medicare Part D Medicare Copayment Medicaid Generic drug Out-of-pocket expenses Prescription medication Formulary Pharmaceuticals policy Health Pharmaceutical sciences		Increasing Copays for Brand Medicines Used by Low-Income Beneficiaries May Compromise Access to Care, Harm Patient Outcomes, and Raise Overall Medicare Costs Add to Reading List Source URL: naminc.org Download Document from Source Website File Size: 199,28 KB Share Document on Facebook

	Centers for Medicare & Medicaid Services, HHS from the clinic or center and the conditions for release of information. (3) The patient’s written consent is required for release of information not authorized to be relea DocID: 1xTVP - View Document
	PDF Document DocID: 1xSUG - View Document
	PDF Document DocID: 1xS2U - View Document
	PDF Document DocID: 1xJXE - View Document
	PDF Document DocID: 1xJnD - View Document